SLC25A39 and colorectal carcinoma: To evaluate the predictive power of SLC25A39 expression for drug response in CRC, including chemotherapy, targeted therapy, small molecule drugs, and immunotherapy, we calculated the IC50 values of 198 drugs in CRC.